The NPNT portfolio presents Trialeco, a modular AI platform for clinical studies. Its public site describes six connected components: Protocol Guard for protocol review, Recruit for pre-screening, Comms for participant communication, Site Status for assessing site readiness, an optional Orchestrator, and a Quality layer. Trialeco Core connects data, roles and the history of actions. The confirmed stage is architecture review and preparation of limited pilots. The team is assembling reference sets, while the open demonstration route uses synthetic data only. Accuracy, speed, completeness and usability are intended to be measured separately for each module. The practical approach is to begin with one process, baseline measure, reference standard, accountable roles and stop conditions rather than the whole platform at once. Any expected process improvement remains a project hypothesis until tested in a pilot. Trialeco does not make decisions about a person: medical assessment, confirmation of protocol fit and study inclusion remain with an authorised professional. The public demo is not an operational medical system and must not contain real patient data.
Project review
Trialeco: six modules for a verifiable clinical-study workflow
The NPNT portfolio presents Trialeco, a modular AI platform for clinical studies. Its public site describes six connected components: Protocol Guard for protocol review, Recruit for pre-screening, Comms for participant communication, Site Status for assessing site readiness, an optional Orchestrator, and a Quality layer. Trialeco Core connects data, roles and the history of actions. The confirmed stage is architecture review and preparation of limited pilots. The team is assembling reference sets, while the open demonstration route uses synthetic data only. Accuracy, speed, completeness and usability are intended to be measured separately for each module. The practical approach is to begin with one process, baseline measure, reference standard, accountable roles and stop conditions rather than the whole platform at once. Any expected process improvement remains a project hypothesis until tested in a pilot. Trialeco does not make decisions about a person: medical assessment, confirmation of protocol fit and study inclusion remain with an authorised professional. The public demo is not an operational medical system and must not contain real patient data.